Participant disposition
When enrollment was stopped in April 2021, 135 participants had been screened, and 105 had been randomized: 34 to amcenestrant 400 mg, 36 to amcenestrant 200 mg, and 35 to letrozole (Fig. CONSORT diagram. Abbreviations: ITT, intent-to-treat; mITT, modified intent-to-treat